Improving hospital performance in the treatment of febrile neutropenia

Barry Meisenberg, Jan Clemons, John Ness, Nancy Faust, Mary Clance

Research output: Contribution to journalArticle

Abstract

Results: Sixty-nine episodes of FN were identified. Ten distinct improvement steps were implemented. Median time to antibiotics was reduced from 252 min, to 188 min and 118 min for the baseline, transitional, and post-intervention groups, respectively (p = 0.0002 for the baseline vs. the post-intervention group comparison). Variability was reduced with the inter-quartile range falling from 174 min (baseline) to 65 min (post-intervention). Despite improvement, there were persisting episodes of delays, due to competing priorities from other patients or decisions to postpone infusion of antibiotics until patients had been admitted. Standardized order sets eliminated improper antibiotic choices as a source of error.

Conclusions: Improvements in the management of FN can be accomplished and sustained by the focused study of performance of individual tasks, the design of streamlined processes by practitioners, and the ongoing review of performance with feedback to clinical departments.

Purpose: Febrile neutropenia (FN) remains a common and dangerous complication of cancer treatment. Guidelines from the Infectious Disease Society of America urge initiating antibiotics within 2 h of presentation. We reviewed our institution’s performance to identify areas of needed improvement and to design performance improvement steps.

Methods: FN management was deconstructed into discrete tasks. Experienced practitioners estimated appropriate time allowance for each task. Cycle time analysis data on a baseline cohort (baseline group) identified causes and loci of delay. Based on these data, new processes to bypass roadblocks for timely therapy were introduced. Performance monitoring continued as these changes were implemented (the transitional group) and for 20 months thereafter (the post-intervention group).

Original languageEnglish (US)
Pages (from-to)371-375
Number of pages5
JournalSupportive Care in Cancer
Volume23
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Febrile Neutropenia
Anti-Bacterial Agents
Task Performance and Analysis
Therapeutics
Communicable Diseases
Research Design
Guidelines
Neoplasms

Keywords

  • Febrile neutropenia
  • Performance improvement

ASJC Scopus subject areas

  • Oncology

Cite this

Meisenberg, B., Clemons, J., Ness, J., Faust, N., & Clance, M. (2014). Improving hospital performance in the treatment of febrile neutropenia. Supportive Care in Cancer, 23(2), 371-375. https://doi.org/10.1007/s00520-014-2377-y

Improving hospital performance in the treatment of febrile neutropenia. / Meisenberg, Barry; Clemons, Jan; Ness, John; Faust, Nancy; Clance, Mary.

In: Supportive Care in Cancer, Vol. 23, No. 2, 2014, p. 371-375.

Research output: Contribution to journalArticle

Meisenberg, B, Clemons, J, Ness, J, Faust, N & Clance, M 2014, 'Improving hospital performance in the treatment of febrile neutropenia', Supportive Care in Cancer, vol. 23, no. 2, pp. 371-375. https://doi.org/10.1007/s00520-014-2377-y
Meisenberg, Barry ; Clemons, Jan ; Ness, John ; Faust, Nancy ; Clance, Mary. / Improving hospital performance in the treatment of febrile neutropenia. In: Supportive Care in Cancer. 2014 ; Vol. 23, No. 2. pp. 371-375.
@article{16bb2eac1f554de2a7593cc7f28b347d,
title = "Improving hospital performance in the treatment of febrile neutropenia",
abstract = "Results: Sixty-nine episodes of FN were identified. Ten distinct improvement steps were implemented. Median time to antibiotics was reduced from 252 min, to 188 min and 118 min for the baseline, transitional, and post-intervention groups, respectively (p = 0.0002 for the baseline vs. the post-intervention group comparison). Variability was reduced with the inter-quartile range falling from 174 min (baseline) to 65 min (post-intervention). Despite improvement, there were persisting episodes of delays, due to competing priorities from other patients or decisions to postpone infusion of antibiotics until patients had been admitted. Standardized order sets eliminated improper antibiotic choices as a source of error.Conclusions: Improvements in the management of FN can be accomplished and sustained by the focused study of performance of individual tasks, the design of streamlined processes by practitioners, and the ongoing review of performance with feedback to clinical departments.Purpose: Febrile neutropenia (FN) remains a common and dangerous complication of cancer treatment. Guidelines from the Infectious Disease Society of America urge initiating antibiotics within 2 h of presentation. We reviewed our institution’s performance to identify areas of needed improvement and to design performance improvement steps.Methods: FN management was deconstructed into discrete tasks. Experienced practitioners estimated appropriate time allowance for each task. Cycle time analysis data on a baseline cohort (baseline group) identified causes and loci of delay. Based on these data, new processes to bypass roadblocks for timely therapy were introduced. Performance monitoring continued as these changes were implemented (the transitional group) and for 20 months thereafter (the post-intervention group).",
keywords = "Febrile neutropenia, Performance improvement",
author = "Barry Meisenberg and Jan Clemons and John Ness and Nancy Faust and Mary Clance",
year = "2014",
doi = "10.1007/s00520-014-2377-y",
language = "English (US)",
volume = "23",
pages = "371--375",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Improving hospital performance in the treatment of febrile neutropenia

AU - Meisenberg, Barry

AU - Clemons, Jan

AU - Ness, John

AU - Faust, Nancy

AU - Clance, Mary

PY - 2014

Y1 - 2014

N2 - Results: Sixty-nine episodes of FN were identified. Ten distinct improvement steps were implemented. Median time to antibiotics was reduced from 252 min, to 188 min and 118 min for the baseline, transitional, and post-intervention groups, respectively (p = 0.0002 for the baseline vs. the post-intervention group comparison). Variability was reduced with the inter-quartile range falling from 174 min (baseline) to 65 min (post-intervention). Despite improvement, there were persisting episodes of delays, due to competing priorities from other patients or decisions to postpone infusion of antibiotics until patients had been admitted. Standardized order sets eliminated improper antibiotic choices as a source of error.Conclusions: Improvements in the management of FN can be accomplished and sustained by the focused study of performance of individual tasks, the design of streamlined processes by practitioners, and the ongoing review of performance with feedback to clinical departments.Purpose: Febrile neutropenia (FN) remains a common and dangerous complication of cancer treatment. Guidelines from the Infectious Disease Society of America urge initiating antibiotics within 2 h of presentation. We reviewed our institution’s performance to identify areas of needed improvement and to design performance improvement steps.Methods: FN management was deconstructed into discrete tasks. Experienced practitioners estimated appropriate time allowance for each task. Cycle time analysis data on a baseline cohort (baseline group) identified causes and loci of delay. Based on these data, new processes to bypass roadblocks for timely therapy were introduced. Performance monitoring continued as these changes were implemented (the transitional group) and for 20 months thereafter (the post-intervention group).

AB - Results: Sixty-nine episodes of FN were identified. Ten distinct improvement steps were implemented. Median time to antibiotics was reduced from 252 min, to 188 min and 118 min for the baseline, transitional, and post-intervention groups, respectively (p = 0.0002 for the baseline vs. the post-intervention group comparison). Variability was reduced with the inter-quartile range falling from 174 min (baseline) to 65 min (post-intervention). Despite improvement, there were persisting episodes of delays, due to competing priorities from other patients or decisions to postpone infusion of antibiotics until patients had been admitted. Standardized order sets eliminated improper antibiotic choices as a source of error.Conclusions: Improvements in the management of FN can be accomplished and sustained by the focused study of performance of individual tasks, the design of streamlined processes by practitioners, and the ongoing review of performance with feedback to clinical departments.Purpose: Febrile neutropenia (FN) remains a common and dangerous complication of cancer treatment. Guidelines from the Infectious Disease Society of America urge initiating antibiotics within 2 h of presentation. We reviewed our institution’s performance to identify areas of needed improvement and to design performance improvement steps.Methods: FN management was deconstructed into discrete tasks. Experienced practitioners estimated appropriate time allowance for each task. Cycle time analysis data on a baseline cohort (baseline group) identified causes and loci of delay. Based on these data, new processes to bypass roadblocks for timely therapy were introduced. Performance monitoring continued as these changes were implemented (the transitional group) and for 20 months thereafter (the post-intervention group).

KW - Febrile neutropenia

KW - Performance improvement

UR - http://www.scopus.com/inward/record.url?scp=84939875186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939875186&partnerID=8YFLogxK

U2 - 10.1007/s00520-014-2377-y

DO - 10.1007/s00520-014-2377-y

M3 - Article

C2 - 25103678

AN - SCOPUS:84939875186

VL - 23

SP - 371

EP - 375

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 2

ER -